MAGQU

Since the start-up in 2008, MagQu has utilized her core technology, so-called ImmunoMagnetic Reduction (IMR), to develop dozens of products, such as in-vitro diagnostic (IVD) assay kits and analyzers for colorectal cancer, Alzheimer's disease, Down's syndrome, preterm birth, inflammatory disease, grouper viruses etc. The R&D and manufacture of products have been certified with both ISO including 9001 and 13485, and GMP. In addition, the immunoassay analyzers have been approved as Class-I Medical Device by Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare. Some of assay kits will be certificated with CE-IVD (2015) and TFDA (2016). We successfully made them on the shelf for life-science markets in China, Japan, Korea, Malaysia, Turkey, USA, UK, and Germany. Up to now, the authorized capital has been raised from 3 million to 1.5 hundred million TWD since 2008. With the bright achievements and impressive progresses, MagQu has been frequently awarded by Ministry of..

Also known as: MagQu Co. Ltd, MagQu LLC

Primary location: Arizona United States